Symbicort (budesonide/formoterol) will be used more for COPD

October 2009

Symbicort (budesonide/formoterol) will be used more for COPD.

It's the second inhaled corticosteroid/beta-agonist combo approved for COPD...along with Advair Diskus (fluticasone/salmeterol).

But these are NOT first-line therapies.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get quote

Table of Contents

Influenza using antivirals and vaccines for the current flu season
computer alert about possible serotonin syndrome when patients get more than one serotonergic drug
Respiratory & Allergy Symbicort (budesonide/formoterol) will be used more for COPD
Diabetes questions about how to switch between insulins
Psychiatry Abilify (a-BILA-fi), a new atypical antipsychotic for schizophrenia and bipolar disorder
Women's Health You'll hear more about limiting antidepressants during pregnancy
Women's Health whether Yaz and Yasmin (drospirenone/ethinyl estradiol) are riskier than other combined oral contraceptives
Cimzia (CIM-zee-uh) for rheumatoid arthritis
Cardiology whether Pradax (dabigatran) will replace warfarin in patients with atrial fibrillation
Cardiology whether a DOUBLE dose of clopidogrel (Plavix) improves outcomes in cardiac patients
Statins questions about resolving statin myopathy
Infectious Diseases new vaccine to prevent shingles called Zostavax